Announce Date | 05/28/2025 |
EPS Normalized Actual | $-0.01102 (Beat by $0.07898) |
EPS GAAP Actual | $-0.01102 (Beat by $0.07898) |
Revenue Actual | $1.96998B |
Revenue Surprise | Beat by $1969.98M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.62585 |
EPS GAAP Estimate | $-0.62585 |
Revenue Estimate | $0.359781554B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.76618 | 5.23 | 2.46975 | 2.96305 | 3 |
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -18.9 | -18.4918 | 1.96998B | 9.86% | 1725.84M |
FQ4 2024 (Dec 2024) | -0.8 | -0.00178 | 2.23214B | 22.83% | 1919.2M |
FQ3 2024 (Sep 2024) | 0 | -1.54141 | 1.88557B | 13.81% | -2244.09M |
FQ2 2024 (Jun 2024) | -1.45 | -2.79259 | 1.89178B | 2.98% | -1779.03M |
FQ4 2018 (Dec 2018) | -5.51 | -5.51 | 0.724341B | 100% | 724.34M |
FQ1 2024 (Mar 2024) | -1.49 | -0.46192 | 1.77568B | -5% | 27.53M |
FQ4 2023 (Dec 2023) | -1.19 | -1.19 | 1.72245B | -23.72% | 1722.45M |
FQ3 2023 (Sep 2023) | -3.31 | -3.31 | 1.62521B | -21.14% | 1625.21M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.62585
Consensus Revenue Estimates
0.359781554B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.3081 | -- | -0.31906 | -0.27767 | 1 |
FQ2 2027 (Jun 2027) | -0.28768 | -- | -0.29792 | -0.25927 | 1 |
FQ1 2027 (Mar 2027) | -0.27748 | -- | -0.28735 | -0.25007 | 1 |
FQ4 2026 (Dec 2026) | -0.53022 | -- | -0.53264 | -0.52543 | 0 |
FQ3 2026 (Sep 2026) | -0.48118 | -- | -0.48338 | -0.47683 | 0 |
FQ2 2026 (Jun 2026) | -0.3831 | -- | -0.38485 | -0.37964 | 0 |
FQ1 2026 (Mar 2026) | -0.33406 | -5557.67 | -0.33559 | -0.33104 | 0 |
FQ4 2025 (Dec 2025) | -0.69839 | -14.55 | -0.76183 | -0.58907 | 1 |
FQ3 2025 (Sep 2025) | -0.62585 | -- | -0.6827 | -0.52789 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.48B | -- | 3.22B | 3.58B | 2 |
FQ2 2027 (Jun 2027) | 2.73B | -- | 2.53B | 2.81B | 2 |
FQ1 2027 (Mar 2027) | 2.36B | -- | 2.18B | 2.43B | 2 |
FQ4 2026 (Dec 2026) | 2.64B | -- | 2.62B | 2.65B | 1 |
FQ3 2026 (Sep 2026) | 2.39B | -- | 2.37B | 2.4B | 1 |
FQ2 2026 (Jun 2026) | 1.88B | -- | 1.86B | 1.88B | 1 |
FQ1 2026 (Mar 2026) | 1.62B | -21.61 | 1.61B | 1.63B | 1 |
FQ4 2025 (Dec 2025) | 0.4B | -460.38 | 0.35B | 0.43B | 0 |
FQ3 2025 (Sep 2025) | 0.36B | -424.09 | 0.32B | 0.38B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.4082 | -18.9 | -18.4918 | 97.84% |
FQ4 2024 (Dec 2024) | -0.79822 | -0.8 | -0.00178 | 0.22% |
FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ2 2024 (Jun 2024) | 1.34259 | -1.45 | -2.79259 | 192.59% |
FQ4 2018 (Dec 2018) | -5.51 | -5.51 | 100% | |
FQ1 2024 (Mar 2024) | -1.02808 | -1.49 | -0.46192 | 31% |
FQ4 2023 (Dec 2023) | -1.19 | -1.19 | 100% | |
FQ3 2023 (Sep 2023) | -3.31 | -3.31 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.24B | $1.97B | $1725.84M | 87.61% |
FQ4 2024 (Dec 2024) | $0.31B | $2.23B | $1919.2M | 85.98% |
FQ3 2024 (Sep 2024) | $4.13B | $1.89B | $-2244.09M | -119.01% |
FQ2 2024 (Jun 2024) | $3.67B | $1.89B | $-1779.03M | -94.04% |
FQ4 2018 (Dec 2018) | $0B | $0.72B | $724.34M | 100% |
FQ1 2024 (Mar 2024) | $1.75B | $1.78B | $27.53M | 1.55% |
FQ4 2023 (Dec 2023) | $0B | $1.72B | $1722.45M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.63B | $1625.21M | 100% |